Latest Form 4 insider transactions

James T. Gottwald, a 10% owner of Tredegar Corp, sold 30,318 shares of common stock on August 11, 2026.

Baris Oran, Chief Financial Officer of Amrize Ltd, purchased 6,000 shares of common stock on August 11, 2026.

Carolyn Monroe, SVP - Title Insurance of Old Republic International Corp, sold 1,788 shares of common stock on August 11, 2026 for $42.26 per share.

Orit Geva-Dvash, Vice President, HR of Camtek Ltd, sold 415 shares of common stock on August 12, 2026 for $174.06 per share.

ZincFive, Inc. and Spark I Acquisition Corporation have confidentially submitted a draft registration statement on Form S-4 with the SEC, a key milestone for their proposed business combination.

David E Rainbolt, a Director and 10% owner of Bancfirst Corp /Ok/, sold 8,506 shares of common stock on August 13, 2026 for $115.00 per share.

William Bardeen, EVP, Chief Financial Officer of New York Times Co, reported a transaction in 485 shares of common stock on August 10, 2026.

Devdatt Kurdikar, President and CEO and a Director of Embecta Corp., purchased 30,000 shares of common stock on August 12, 2026 for $4.70 per share.

Jacob Elguicze, SVP and CFO of Embecta Corp., purchased 20,000 shares of common stock on August 12, 2026 for $4.67 per share.

James Eccher, CHAIRMAN AND CEO and a Director of Old Second Bancorp Inc, sold 19,313 shares of common stock on August 12, 2026 for $25.61 per share.

Jeffrey Z Mann, Pres, Pharm Svc&Prod Mgmt, CLO of Embecta Corp., purchased 20,000 shares of common stock on August 12, 2026 for $4.99 per share.

Randall J. Erickson, Executive Vice President of Associated Banc-Corp, sold 43,561 shares of common stock on August 12, 2026 for $32.04 per share.

Robert J. Hombach, a Director of Embecta Corp., purchased 45,000 shares of common stock on August 12, 2026 for $4.97 per share.

Harvey Edward Snowling, Chief Operating Officer of Borr Drilling Ltd, reported multiple transactions in common stock on August 12, 2026.

Jehan Mawjee, Chief Accounting Officer of Borr Drilling Ltd, reported multiple transactions in common stock on August 12, 2026.

Lior Aviram, a Director of Camtek Ltd, sold 6,694 shares of common stock on August 11, 2026.

Moshe Eisenberg, Chief Financial Officer of Camtek Ltd, sold 4,404 shares of common stock on August 11, 2026.

Magnus Vaaler, Chief Financial Officer of Borr Drilling Ltd, reported multiple transactions in common stock on August 12, 2026.

Ned S Holmes, a Director of Prosperity Bancshares Inc, sold 1,100 shares of common stock on August 12, 2026.

Vireo Growth Inc. presents an investor update detailing substantial Q2 2026 financial growth, strategic acquisitions, and a proposed merger with Planet 13 Holdings Inc. to create a leading U.S. cannabis operator.

Vireo Growth Inc. presents an investor update detailing substantial Q2 2026 financial growth, strategic acquisitions, and a proposed merger with Planet 13 Holdings Inc. to create a leading U.S. cannabis operator.

Hugh E Sawyer Iii, a Director of Huron Consulting Group Inc., sold 2,000 shares of common stock on August 11, 2026 for $154.25 per share.

Stephen Dean Young, Chief Strategy Officer of SouthState Corp, reported a transaction in 3,000 shares of common stock on August 12, 2026.

Richard Ian Griffiths, a 10% owner of Silence Therapeutics plc, reported multiple transactions in common stock on August 10, 2026.

John C Corbett, CEO and a Director of SouthState Corp, reported a transaction in 5,000 shares of common stock on August 12, 2026.

Lynx1 Capital Management LP and 1 other reported changes in beneficial ownership of Korro Bio, Inc. common stock on August 6, 2026.

Liron Eizenman, President and CEO of Silicom Ltd., sold 18,072 shares of common stock on August 12, 2026 for $48.53 per share.

Richard M Hutson Ii, a Director of Investors Title Co, received 212 shares of common stock on August 12, 2026.

Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., sold 411 shares of common stock on August 12, 2026 for $16.07 per share.

David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 230 shares of common stock on August 12, 2026 for $16.07 per share.